Treatment of metastatic renal cell carcinoma with low-dose interleukin-2

被引：0
|
作者：
Takezawa, Yuta [1 ]
Izumi, Kouji [1 ]
Nohara, Takahiro [1 ]
Narimoto, Kazutaka [1 ]
Ueno, Satoru [1 ]
Kadono, Yoshihumi [1 ]
Kitagawa, Yasuhide [1 ]
Konaka, Hiroyuki [1 ]
Mizokami, Atsushi [1 ]
Namiki, Mikio [1 ]
机构：
[1] Kanazawa Univ, Dept Urol, Kanazawa, Ishikawa 9201192, Japan
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-6-8
引用
收藏
页码：145 / 145
页数：1
相关论文
共 50 条
  • [1] LOW-DOSE INTERLEUKIN-2 IN THE TREATMENT OF METASTATIC RENAL-CELL CARCINOMA
    STADLER, WM
    VOGELZANG, NJ
    SEMINARS IN ONCOLOGY, 1995, 22 (01) : 67 - 73
  • [2] Treatment Outcome of Low-dose Interleukin-2 Therapy in Patients with Metastatic Renal Cell Carcinoma
    Takezawa, Yuta
    Izumi, Kouji
    Shimura, Yusuke
    Aerken, Maolake
    Natsagdorji, Ariunbold
    Iijima, Masashi
    Shigehara, Kazuyoshi
    Nohara, Takahiro
    Narimoto, Kazutaka
    Kadono, Yoshifumi
    Kitagawa, Yasuhide
    Konaka, Hiroyuki
    Mizokami, Atsushi
    ANTICANCER RESEARCH, 2016, 36 (09) : 4961 - 4964
  • [3] LOW-DOSE REGIMEN OF INTERLEUKIN-2 FOR METASTATIC RENAL-CARCINOMA
    SLEIJFER, DT
    JANSSEN, RAJ
    WILLEMSE, PHB
    MARTENS, A
    DELEIJ, L
    DEVRIES, EGE
    MULDER, NH
    LANCET, 1990, 335 (8704): : 1522 - 1523
  • [4] Chemoimmunotherapy with low dose vinorelbine and interleukin-2 in treatment of patients with metastatic renal cell carcinoma
    Mencoboni, M. P.
    Tredici, S.
    Varaldo, M.
    Queirolo, G.
    Durand, F.
    Rebella, L.
    Galbusera, V.
    Pannacciulli, I. M.
    Ghio, R.
    NEOPLASMA, 2006, 53 (04) : 333 - 336
  • [5] LACK OF EFFICACY OF LOW-DOSE SUBCUTANEOUS RECOMBINANT INTERLEUKIN-2 AND INTERFERON-ALPHA IN THE TREATMENT OF METASTATIC RENAL-CELL CARCINOMA
    THIOUNN, N
    MATHIOT, C
    DORVAL, T
    FLAM, TA
    TARTOUR, E
    MOSSERI, V
    ZERBIB, M
    FRIDMAN, WH
    DEBRE, B
    BRITISH JOURNAL OF UROLOGY, 1995, 75 (05): : 586 - 589
  • [6] High-dose interleukin-2 in metastatic renal cell carcinoma
    Fernández-Rodríguez, R
    de Argumedo, GL
    Mañé, JM
    Muñoz, A
    Ferreiro, J
    Fuente, N
    López-Vivanco, G
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (27) : 6797 - 6798
  • [7] Low-dose intravenous bolus interleukin-2 with interferon-alpha therapy for metastatic melanoma and renal cell carcinoma
    Karp, SE
    JOURNAL OF IMMUNOTHERAPY, 1998, 21 (01): : 56 - 61
  • [8] SUBCUTANEOUS LOW-DOSE RECOMBINANT INTERLEUKIN-2 AND ALPHA-INTERFERON IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA
    RAVAUD, A
    NEGRIER, S
    CANY, L
    MERROUCHE, Y
    LEGUILLOU, M
    BLAY, JY
    CLAVEL, M
    GASTON, R
    OSKAM, R
    PHILIP, T
    BRITISH JOURNAL OF CANCER, 1994, 69 (06) : 1111 - 1114
  • [9] A phase II study of subcutaneous low-dose interleukin-2 plus erythropoietin in metastatic cell carcinoma progressing on interleukin-2 alone
    Lissoni, P
    Rovelli, F
    Baiocco, N
    Tangini, G
    Fumagalli, L
    ANTICANCER RESEARCH, 2001, 21 (1B) : 777 - 779
  • [10] A phase II trial of low-dose interleukin-2 (IL-2) and bevacizumab in patients with metastatic renal cell carcinoma (mRCC)
    Garcia, J. A.
    Rini, B. I.
    Mekhail, T.
    Triozzi, P.
    Elson, P.
    Nemec, C.
    Bukowski, R. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345